Paper39130445
HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS.
Phipps AJ and 14 others. Heliyon, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS. Papers, record 39130445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39130445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27957719 | Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease. | Neurotherapeutics | 2017 | https://conductscience.org/library/papers/27957719 | PubMed |
| 2 | 30309882 | Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. | J Neurol Neurosurg Psychiatry | 2019 | https://conductscience.org/library/papers/30309882 | PubMed |
| 3 | 24073237 | Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. | PLoS One | 2013 | https://conductscience.org/library/papers/24073237 | PubMed |
| 4 | 31705657 | Microtubule-dependent processes precede pathological calcium influx in excitotoxin-induced axon degeneration. | J Neurochem | 2020 | https://conductscience.org/library/papers/31705657 | PubMed |
| 5 | 24932665 | Interplay between HDAC6 and its interacting partners: essential roles in the aggresome-autophagy pathway and neurodegenerative diseases. | DNA Cell Biol | 2014 | https://conductscience.org/library/papers/24932665 | PubMed |
| 6 | 36705941 | An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. | Expert Rev Neurother | 2023 | https://conductscience.org/library/papers/36705941 | PubMed |
| 7 | 15579172 | Benefit of valproic acid in suppressing disease progression of ALS model mice. | Eur J Neurosci | 2004 | https://conductscience.org/library/papers/15579172 | PubMed |
| 8 | 17934327 | Axonal degeneration in motor neuron disease. | Neurodegener Dis | 2007 | https://conductscience.org/library/papers/17934327 | PubMed |
| 9 | 32877582 | Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32877582 | PubMed |
| 10 | 21712032 | Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. | Exp Neurol | 2011 | https://conductscience.org/library/papers/21712032 | PubMed |
| 11 | 26485052 | A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. | J Vis Exp | 2015 | https://conductscience.org/library/papers/26485052 | PubMed |
| 12 | 23463871 | Pathophysiological insights into ALS with C9ORF72 expansions. | J Neurol Neurosurg Psychiatry | 2013 | https://conductscience.org/library/papers/23463871 | PubMed |
| 13 | 17522299 | Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. | J Neurosci | 2007 | https://conductscience.org/library/papers/17522299 | PubMed |
| 14 | 30555293 | The HDAC6 Inhibitor Trichostatin A Acetylates Microtubules and Protects Axons From Excitotoxin-Induced Degeneration in a Compartmented Culture Model. | Front Neurosci | 2018 | https://conductscience.org/library/papers/30555293 | PubMed |
| 15 | 15934930 | Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. | J Neurochem | 2005 | https://conductscience.org/library/papers/15934930 | PubMed |
| 16 | 35354901 | NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone. | Sci Rep | 2022 | https://conductscience.org/library/papers/35354901 | PubMed |
| 17 | 11050249 | Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/11050249 | PubMed |
| 18 | 16167067 | HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. | Cell Death Differ | 2006 | https://conductscience.org/library/papers/16167067 | PubMed |
| 19 | 21909419 | Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. | PLoS One | 2011 | https://conductscience.org/library/papers/21909419 | PubMed |
| 20 | 29054467 | The multi-dimensional roles of astrocytes in ALS. | Neurosci Res | 2018 | https://conductscience.org/library/papers/29054467 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42875680 | Restoring Neural Homeostasis via Class II HDAC Modulation: Mechanistic Insights and Therapeutic Opportunities. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42875680 | PubMed |
| 42481875 | The centrosome-cilium-centriolar satellite axis in neurodegenerative diseases. | EMBO Rep | 2026 | https://conductscience.org/library/papers/42481875 | PubMed |
| 41378251 | Molecular and cellular mechanisms of pentadecanoic acid. | World J Biol Chem | 2025 | https://conductscience.org/library/papers/41378251 | PubMed |
| 41237781 | Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models. | Stem Cell Reports | 2025 | https://conductscience.org/library/papers/41237781 | PubMed |
| 41061670 | A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia. | Brain | 2026 | https://conductscience.org/library/papers/41061670 | PubMed |
| 40641131 | Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40641131 | PubMed |
| 40593212 | Impact of Histone Acetyltransferases and Histone Deacetylases on Adult Brain Myelin Plasticity. | Results Probl Cell Differ | 2025 | https://conductscience.org/library/papers/40593212 | PubMed |
| 40542954 | Single-Nucleus RNA Sequencing of HDAC6 Inhibition in Resolving Doxorubicin-Induced Cognitive Impairment. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40542954 | PubMed |
| 40333935 | Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder. | Ann Clin Transl Neurol | 2025 | https://conductscience.org/library/papers/40333935 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39130445
GET https://conductscience.org/api/papers/v1/39130445/references?page=2